EXAS
Price
$48.49
Change
-$0.28 (-0.57%)
Updated
Jul 25, 04:59 PM (EDT)
Capitalization
12.78B
12 days until earnings call
SNN
Price
$31.67
Change
+$0.19 (+0.60%)
Updated
Jul 25, 04:59 PM (EDT)
Capitalization
10.95B
11 days until earnings call
Interact to see
Advertisement

EXAS vs SNN

Header iconEXAS vs SNN Comparison
Open Charts EXAS vs SNNBanner chart's image
Exact Sciences
Price$48.49
Change-$0.28 (-0.57%)
Volume$17.33K
Capitalization12.78B
Smith & Nephew
Price$31.67
Change+$0.19 (+0.60%)
Volume$11.04K
Capitalization10.95B
EXAS vs SNN Comparison Chart in %
Loading...
EXAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EXAS vs. SNN commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXAS is a Hold and SNN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (EXAS: $48.77 vs. SNN: $31.48)
Brand notoriety: EXAS: Notable vs. SNN: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: EXAS: 88% vs. SNN: 78%
Market capitalization -- EXAS: $12.78B vs. SNN: $10.95B
EXAS [@Medical Specialties] is valued at $12.78B. SNN’s [@Medical Specialties] market capitalization is $10.95B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EXAS’s FA Score shows that 0 FA rating(s) are green whileSNN’s FA Score has 1 green FA rating(s).

  • EXAS’s FA Score: 0 green, 5 red.
  • SNN’s FA Score: 1 green, 4 red.
According to our system of comparison, SNN is a better buy in the long-term than EXAS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EXAS’s TA Score shows that 3 TA indicator(s) are bullish while SNN’s TA Score has 5 bullish TA indicator(s).

  • EXAS’s TA Score: 3 bullish, 6 bearish.
  • SNN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SNN is a better buy in the short-term than EXAS.

Price Growth

EXAS (@Medical Specialties) experienced а -6.59% price change this week, while SNN (@Medical Specialties) price change was +5.35% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.88%. For the same industry, the average monthly price growth was +5.07%, and the average quarterly price growth was -2.40%.

Reported Earning Dates

EXAS is expected to report earnings on Aug 06, 2025.

SNN is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Medical Specialties (+2.88% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EXAS($12.8B) has a higher market cap than SNN($10.9B). SNN YTD gains are higher at: 30.189 vs. EXAS (-13.205). SNN has higher annual earnings (EBITDA): 956M vs. EXAS (29.3M). EXAS has more cash in the bank: 778M vs. SNN (302M). EXAS has less debt than SNN: EXAS (2.56B) vs SNN (3.08B). SNN has higher revenues than EXAS: SNN (5.55B) vs EXAS (2.5B).
EXASSNNEXAS / SNN
Capitalization12.8B10.9B117%
EBITDA29.3M956M3%
Gain YTD-13.20530.189-44%
P/E RatioN/A40.76-
Revenue2.5B5.55B45%
Total Cash778M302M258%
Total Debt2.56B3.08B83%
FUNDAMENTALS RATINGS
EXAS vs SNN: Fundamental Ratings
EXAS
SNN
OUTLOOK RATING
1..100
5922
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
6
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9794
PRICE GROWTH RATING
1..100
6245
P/E GROWTH RATING
1..100
10086
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNN's Valuation (6) in the Medical Specialties industry is somewhat better than the same rating for EXAS (42) in the Biotechnology industry. This means that SNN’s stock grew somewhat faster than EXAS’s over the last 12 months.

SNN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as EXAS (100) in the Biotechnology industry. This means that SNN’s stock grew similarly to EXAS’s over the last 12 months.

SNN's SMR Rating (94) in the Medical Specialties industry is in the same range as EXAS (97) in the Biotechnology industry. This means that SNN’s stock grew similarly to EXAS’s over the last 12 months.

SNN's Price Growth Rating (45) in the Medical Specialties industry is in the same range as EXAS (62) in the Biotechnology industry. This means that SNN’s stock grew similarly to EXAS’s over the last 12 months.

SNN's P/E Growth Rating (86) in the Medical Specialties industry is in the same range as EXAS (100) in the Biotechnology industry. This means that SNN’s stock grew similarly to EXAS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EXASSNN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
39%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
63%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
48%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
44%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
53%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
58%
Advances
ODDS (%)
Bullish Trend 17 days ago
71%
Bullish Trend 3 days ago
54%
Declines
ODDS (%)
Bearish Trend 5 days ago
81%
Bearish Trend 11 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
52%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
EXAS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AIVC55.220.94
+1.73%
Amplify Bloomberg AI Value Chain ETF
EVX38.970.12
+0.32%
VanEck Environmental Svcs ETF
QGRO109.740.08
+0.07%
American Century US Quality Growth ETF
HCOW23.94-0.07
-0.27%
Amplify COWS Covered Call ETF
TWN45.47-0.73
-1.58%
Taiwan Fund

EXAS and

Correlation & Price change

A.I.dvisor indicates that over the last year, EXAS has been loosely correlated with ILMN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if EXAS jumps, then ILMN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXAS
1D Price
Change %
EXAS100%
-2.13%
ILMN - EXAS
34%
Loosely correlated
+2.90%
XRAY - EXAS
33%
Poorly correlated
-2.31%
BRKR - EXAS
33%
Poorly correlated
+1.35%
LH - EXAS
32%
Poorly correlated
+6.86%
SNN - EXAS
32%
Poorly correlated
-1.13%
More

SNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNN has been loosely correlated with SYK. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SNN jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNN
1D Price
Change %
SNN100%
-1.13%
SYK - SNN
48%
Loosely correlated
-1.07%
ALC - SNN
46%
Loosely correlated
-0.35%
IDXX - SNN
45%
Loosely correlated
+3.38%
TFX - SNN
44%
Loosely correlated
-0.89%
LH - SNN
39%
Loosely correlated
+6.86%
More